Von Willebrand Disease: Range of the Disease, and Management

被引:0
|
作者
Fernández K.S. [1 ]
de Alarcón P.A. [1 ,2 ]
机构
[1] Department of Pediatrics, Division of Hematology/Oncology, Children’s Hospital of Illinois, University of Illinois College of Medicine at Peoria, 530 NE Glen Oak Ave, Peoria, IL
[2] William H. Albers Professor and Chair, Department of Pediatrics, University of Illinois College of Medicine, Peoria, IL
关键词
Children; Management; Von Willebrand disease (VWD);
D O I
10.1007/s40124-013-0035-3
中图分类号
学科分类号
摘要
Von Willebrand disease is the most common autosomal inherited bleeding disorder. It is caused by quantitative or qualitative defects of the von Willebrand factor. The International Society of Thrombosis and Hemostasis recognizes three types of Von Willebrand disease, with four qualitative subtypes, i.e. six different groups in total. All variants present with mucocutaneous bleeding of variable severity depending on the penetrance of the disease, the level of von Willebrand factor (VWF), and the specific abnormality of the defect, resulting in altered VWF interactions between either platelets and collagen or factor VIII. Diagnosis is difficult because the clinical and laboratory phenotypes are very heterogeneous and may overlap for normal subjects. The molecular pathology of the condition corresponds to the specific variants but has a wide range of genetic mechanisms. Accurate diagnosis of the disorder is of critical importance to establish appropriate treatment options for individual patients. This review covers the pathophysiology and genetics of the condition, the diagnostic classification, testing, and the available treatments, specifically highlighting the population. © 2013, Springer Science + Business Media New York.
引用
收藏
页码:60 / 70
页数:10
相关论文
共 50 条
  • [41] Management of type 2b von Willebrand disease in the neonatal period
    Proud, Lindsay
    Ritchey, A. Kim
    PEDIATRIC BLOOD & CANCER, 2017, 64 (01) : 103 - 105
  • [42] Diagnosing von Willebrand disease: genetic analysis
    Goodeve, Anne
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 678 - 682
  • [43] Utility of thromboelastography for the diagnosis of von Willebrand disease
    Regling, Katherine
    Kakulavarapu, Srikruthi
    Thomas, Ronald
    Hollon, Wendy
    Chitlur, Meera B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [44] New treatment approaches to von Willebrand disease
    Lavin, Michelle
    O'Donnell, James S.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 683 - 689
  • [45] Gastrointestinal angiodysplasia and bleeding in von Willebrand disease
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (03) : 427 - 431
  • [46] Feasibility of the Von Willebrand disease PREVENT trial
    Ragni, Margaret V.
    Machin, Nicoletta
    James, Andra H.
    Seaman, Craig D.
    Malec, Lynn M.
    Kessler, Craig M.
    Konkle, Barbara A.
    Kouides, Peter A.
    Neff, Anne T.
    Philipp, Claire S.
    Brooks, Maria M.
    THROMBOSIS RESEARCH, 2017, 156 : 8 - 13
  • [47] Flexible Ureteroscopy in Children with von Willebrand Disease
    Christman, Matthew S.
    Ziemba, Justin
    Casale, Pasquale
    JOURNAL OF ENDOUROLOGY, 2012, 26 (07) : 783 - 786
  • [48] Bleeding Scores for the Diagnosis of von Willebrand Disease
    Bowman, Mackenzie L.
    James, Paula D.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (05): : 530 - 539
  • [49] Vonicog alfa for the treatment of von Willebrand disease
    Castaman, Giancarlo
    Linari, Silvia
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (05): : 549 - 554
  • [50] New advances in the diagnosis of von Willebrand disease
    Sharma, Ruchika
    Haberichter, Sandra L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 596 - 600